Boston Scientific closes on $615M Apollo Endosurgery deal

Boston Scientific has closed on its $615 million acquisition of gastroenterology device company Apollo Endosurgery.

Boston Scientific announced its plan to acquire the company for $10 per share in November. 

Apollo's main focus is on the design, development and commercialization of less invasive gastrointestinal and endoscopic devices. 

This acquisition will mark Boston Scientific's entry into the endobariatric market, according to an April 4 news release shared with Becker's

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast